Glutathione vials are large: a common presentation holds more than a thousand milligrams, and the dose is a fraction of it. That makes the water volume the decisive input, and it makes unit errors expensive.
Below the calculator: a reconstitution chart sized for large vials, the dose envelope per experience level, the cycle length, a supplies plan, the health conditions that change the answer, and the references. Every dose figure is read from the Klarovel engine's dose table, never typed into the page.
How many milligrams are in your Glutathione vial?
How much bacteriostatic water are you adding?
Syringe size
Experience with injectable peptides
Selects the dose row the engine would use, which changes the target, the upper bound and the ceiling together.
Body weight
The engine catalog does not flag Glutathione weight sensitive, and the dose calculator applies no generic weight scaling, so this does not change the target. Inventing a per-kilogram rule would be worse than leaving it alone.
Standard dose at the beginner level
66.7 units
200 mg
Frequency for this level: 3 times weekly. Timing: Any time. Route: subcutaneous.
The three phases in the order the engine escalates a dose, with the unit mark for each at 600 mg in 2 ml. Change the experience level, weight or age above and the whole table recomputes.
| Phase | Dose | Draw | Doses per vial |
|---|---|---|---|
| Phase 1, opening dose | 150 mg | 50.0 units | 4 |
| Phase 2, standard dose | 200 mg | 66.7 units | 3 |
| Phase 3, upper dose | 250 mg | 83.3 units | 2 |
| Ceiling, not exceeded | 300 mg | 100.0 units | 2 |
Doses read from the beginner row of dose_protocols, the engine's dose table. Unit marks are arithmetic over your vial size and water volume.
Every level side by side, unmodified. This is the raw dose table, so the shape of the ramp is visible instead of collapsed into a single recommended number.
| Experience | Opening | Standard | Upper | Ceiling | Frequency |
|---|---|---|---|---|---|
| Never used peptides | 100 mg | 150 mg | 200 mg | 200 mg | twice weekly |
| Researched, not used | 100 mg | 150 mg | 200 mg | 200 mg | 2-3 times weekly |
| Beginner | 150 mg | 200 mg | 250 mg | 300 mg | 3 times weekly |
| Intermediate | 200 mg | 250 mg | 300 mg | 400 mg | 3-4 times weekly |
| Experienced | 250 mg | 300 mg | 400 mg | 600 mg | 3-5 times weekly |
Every cell read verbatim from dose_protocols. Where a level repeats the same figure across columns, that is what the table holds: no ramp has been invented to fill the row.
Pre-calculated syringe units for every water volume against the dose figures this compound actually uses, at your selected vial size of 600 mg. A cell reading "n/a" means the draw exceeds a 100-unit syringe at that concentration.
| BAC water | Conc. | Opening150 mg | Standard200 mg | Upper250 mg | Ceiling300 mg |
|---|---|---|---|---|---|
| 1 ml | 600 mg/ml | 25 | 33.3 | 41.7 | 50 |
| 1.5 ml | 400 mg/ml | 37.5 | 50 | 62.5 | 75 |
| 2 ml | 300 mg/ml | 50 | 66.7 | 83.3 | 100 |
| 2.5 ml | 240 mg/ml | 62.5 | 83.3 | n/a | n/a |
| 3 ml | 200 mg/ml | 75 | 100 | n/a | n/a |
| 4 ml | 150 mg/ml | 100 | n/a | n/a | n/a |
| 5 ml | 120 mg/ml | n/a | n/a | n/a | n/a |
Column doses are the beginner row's opening, standard, upper and ceiling figures from dose_protocols. Unit marks are arithmetic.
One on-cycle runs 12 weeks followed by 4 weeks off, from the engine catalog. Multiplied out at the standard dose and your mix, that is what the cycle costs in consumables.
| Cycle length | 12 weeks on, 4 weeks off |
|---|---|
| Administrations per week | 3 |
| Total administrations | 36 |
| Vials of 600 mg | 12 |
| Insulin syringes | 36 (100-unit holds the draw) |
| Bacteriostatic water | 24 ml, 3 bottles of 10 ml |
Cycle length, loading phase and taper from PEPTIDE_CATALOG. Administrations per week derived from the frequency string on the dose row. Counts are arithmetic.
Free founding-member access while spots last. We'll send your reconstitution + a link to claim your slot.
Glutathione is a tripeptide of glutamate, cysteine and glycine, and the body's principal intracellular antioxidant. Its biosynthesis, turnover and role in redox balance are among the better characterised subjects in this catalog.
The oral route is the well-studied one in humans: randomised supplementation trials have measured body stores after oral and liposomal dosing. Injectable glutathione has far less controlled human dosing data behind it, and it is worth saying so plainly rather than implying the injectable route inherits the oral evidence base.
A note on units, because this is where glutathione pages go wrong. The dose is in milligrams, not micrograms. An earlier Klarovel research row carried a comparable compound in micrograms when the real figure was milligrams, a thousandfold error. The calculator reads the unit from the engine dose table and never infers it from the size of the number.
| Route | subcutaneous |
|---|---|
| Timing | Any time |
| Catalog frequency | once daily |
| Cycle | 12 weeks on, 4 weeks off |
| Taper before the off period | Not specified |
| Loading phase | None |
| Weight sensitive | No |
Catalog note: Inject subcutaneously or intramuscularly. Master antioxidant. Supports detoxification and immune function.
Every row above is read from PEPTIDE_CATALOG, the engine catalog, and the note is quoted verbatim rather than paraphrased.
A public page cannot know your health data, so it cannot tell you whether a compound is appropriate. What it can do is list the conditions the engine's contraindication matrix associates with this compound, and what the engine does about each. In a generated protocol these resolve automatically and the reason is shown alongside the exclusion.
The engine's contraindication matrix carries no rule that names this compound or its category. That is what the matrix holds, not a statement that nothing is worth discussing with a clinician. Age and kidney or liver impairment apply across the catalog regardless.
These papers cover glutathione biosynthesis, metabolism, redox function and the human supplementation trials. The controlled human dosing data concerns oral and liposomal routes; the injectable route has less of it, and the dose figures on this page come from the engine dose table rather than from these papers.
The dose figures on this page are not sourced from these papers. They are read from the Klarovel engine's own dose table, which is cited inline wherever a number appears. These references cover mechanism, pharmacology and clinical context.
18 references, every identifier resolved against NCBI on 2026-07-30. Per peptide, a relevance-sorted esearch was run and every returned id was resolved through esummary. Any id esummary could not resolve was dropped, and any record carrying the 'Retracted Publication' pubtype was dropped. Titles, journals, years and first authors below are the values esummary returned, not authored text. One retracted record was dropped: PMID 37696839 (thymosin beta 4 query).
Beyond the arithmetic
A calculator converts a dose into syringe units. The Klarovel engine decides the dose: it reads your health data, resolves contraindications, sets the envelope by experience level, removes incompatible pairs and builds the cycling and monitoring schedule. Blood work is optional and sharpens the result. It is never required.